Professor Prof Cheng-Hock Toh CBE sat down with us for a Q&A after being awarded a CBE about his role at the University and what he does outside of research. Read the whole interview here➡️: tinyurl.com/4bz3tfat

Looking forward to being ⁦Royal College of Physicians⁩ for #RCPMed22. Looking forward to re-connecting with Ian Roberts ⁦London School of Hygiene & Tropical Medicine⁩ - the guru of tranexamic acid evidence lshtm.ac.uk/newsevents/exp…

Spring Royal College of Physicians today: 24 hours till close of voting for the new spring of the next RCP President

This The Lancet Comment has not been written from an ivory tower perspective. Not quixotic - to quote @RichardHaynes3

The panel has been deliberating for more than 16 hours but still has not reached decisions bbc.in/3eaHRzv

Rethinking coagulation: histones add the "immuno" to haemostasis and #thrombosis. Prof Cheng-Hock Toh CBE Jun Yong bit.ly/3HMhGuU

Really helpful review in our latest issue by Prof Cheng-Hock Toh CBE and Jeremy Schofield on how to manage acute thrombosis and thrombocytopenia. rcpjournals.org/content/clinme…

In a NHS England blog, Nnenna Osuji and I highlight the important genotyping initiative to improve blood matching for patients with sickle cell disease & thalassaemia. england.nhs.uk/blog/personali… NHS Blood+Transplant North Middlesex Sickle Cell Society UK Thalassaemia Society

After years of work, a nice Christmas 🎁 from @BloodJournal pdf.sciencedirectassets.com/778769/1-s2.0-…

Delighted to make the front cover of the ⁦The BMJ⁩ today. Thank you ⁦Prof Cheng-Hock Toh CBE⁩ for your support in developing this manuscript and for your support in initiating and growing ⁦HaemSTAR 💙⁩

Writing in The BMJ, former RCP academic vice president Prof Cheng-Hock Toh CBE (Prof Cheng-Hock Toh CBE) and colleagues describe the ‘rewarding and worthwhile career’ that clinical research can offer to doctors: bmj.com/content/385/bm…

1. Research improves patient outcome 2. Research improves doctors satisfaction Check out pubmed.ncbi.nlm.nih.gov/37775179/ @RichardHaynes3 Martin Landray

After stopping anticoagulation beyond 1⃣st episode of unprovoked venous thromboembolism, pulmonary embolism and deep vein thrombosis recurrences are frequent but have low case fatality rates (CFRs), while major bleeding is rare, but has high CFRs. World Thrombosis Day #thrombosis

Profound harm has been done to the individuals and families affected by infected blood. For many, the inquiry’s report has sadly come too late, but its recommendations can still stop a growing complacency over transfusion practices Prof Cheng-Hock Toh CBE Elisabeth Buggins bmj.com/content/385/bm…

Fibrinogen buffers the cytotoxicity of circulating histones in vivo and ratios of histones to fibrinogen help identify critically ill patients at highest risk of mortality, who might benefit from anti-histone therapy. Prof Cheng-Hock Toh CBE Simon Abrams Jun Yong jthjournal.org/article/S1538-…

Fibrinogen buffers the cytotoxicity of circulating histones in vivo and ratios of histones to fibrinogen help identify critically ill patients at highest risk of mortality, who might benefit from anti-histone therapy. Prof Cheng-Hock Toh CBE Simon Abrams Jun Yong jthjournal.org/article/S1538-…

To use or not to use reversal agents for DOACs? 🤔 Not all DOAC-associated bleeds require reversal. This table summarizes guidance from ISTH SSC on this issue ✍️Jerrold Levy, MD Lana Castellucci @connors_md Deborah Siegal Read this important paper at jthjournal.org/article/S1538-…

Article in press!Pathogenic circulating tumor DNA predicts the risk of #VTE in cancer patients.